K Ohyashiki
Overview
Explore the profile of K Ohyashiki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
293
Citations
3146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Katagiri S, Akahane D, Amano K, Ohyashiki K
Haemophilia
. 2016 Sep;
22(6):e557-e559.
PMID: 27641423
No abstract available.
2.
Tauchi T, Ohyashiki K, Kodama A, Iwabuchi A, Ohyashiki J, Toyama K
Leuk Lymphoma
. 2016 Jul;
2(1-2):131-5.
PMID: 27456580
We report two cases of acute nonlymphocytic leukemia (ANLL) in which the circulating leukemic cells showed trisomy of chromosome 4 as the sole cytogenetic abnormality. Trisomy 4 is rarely found...
3.
Gotoh M, Yoshizawa S, Katagiri S, Suguro T, Asano M, Kitahara T, et al.
Transpl Infect Dis
. 2014 May;
16(3):440-9.
PMID: 24810656
Background: Viral infections and their occult reactivation occasionally cause not only organ damage, but also exacerbation of acute graft-versus-host disease (aGVHD), which may increase transplantation-related mortality synergistically. To determine correlations...
4.
Gotoh M, Yoshizawa S, Katagiri S, Suguro T, Asano M, Kitahara T, et al.
Bone Marrow Transplant
. 2014 Apr;
49(7):955-60.
PMID: 24732960
Non-remitting patients with hematologic myeloid malignancies have poor prognosis. To overcome this problem, we investigated the use of reduced-intensity preconditioning umbilical cord blood transplantation (RICBT) combined with recombinant G-CSF (rG-CSF)...
5.
Schanz J, Tuchler H, Sole F, Mallo M, Luno E, Cervera J, et al.
Leukemia
. 2013 Jun;
27(10):1988-95.
PMID: 23787396
Monosomal karyotype (MK) is associated with an adverse prognosis in patients in acute myeloid leukemia (AML). This study analyzes the prognostic impact of MK in a cohort of primary, untreated...
6.
Yoshizawa S, Ohyashiki J, Ohyashiki M, Umezu T, Suzuki K, Inagaki A, et al.
Blood Cancer J
. 2012 Jul;
2(1):e53.
PMID: 22829237
Recent studies have demonstrated that one-third of known microRNAs (miRNAs) are stably detectable in plasma. Therefore, we assessed plasma miRNAs to investigate the dynamics of oncomir 17-92a, which is highly...
7.
Umezu T, Ohyashiki K, Kuroda M, Ohyashiki J
Oncogene
. 2012 Jul;
32(22):2747-55.
PMID: 22797057
Recent findings indicate that specific microRNAs (miRNAs), such as those of the miR-17-92 cluster, may be responsible for regulating endothelial gene expression during tumor angiogenesis. Secreted miRNAs enclosed in exosomes...
8.
Kume K, Kikukawa M, Hanyu H, Takata Y, Umahara T, Sakurai H, et al.
Eur J Neurol
. 2012 Feb;
19(6):905-10.
PMID: 22288427
Background And Purpose: Shortened telomere length has been considered to be associated with various age-related diseases, especially in dementia such as Alzheimer's disease and vascular dementia. However, changes in telomere...
9.
Ohyashiki K, Ohyashiki J, Iwama H, Hayashi S, Shay J, Toyama K
Int J Oncol
. 2011 May;
8(3):417-21.
PMID: 21544377
We utilized fluorescent-labeled primers and modified the telomeric repeal amplification protocol (TRAP) to assess telomerase activity during the process of in vitro establishment in four different leukemia cell lines. We...
10.
Uchida Y, Miyazawa K, Yaguchi M, Gotoh A, Iwase O, Ohyashiki K, et al.
Int J Oncol
. 2011 May;
10(6):1103-7.
PMID: 21533490
We established a new lymphoma cell line, designated CTB-1, from pericardial effusion of a patient with diffuse large B-cell lymphoma. This cell line showing vigorous growth ability has undergone 260...